ARMISTICE CAPITAL, LLC - 10 Mar 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director, 10%+ Owner
Signature
ARMISTICE CAPITAL, LLC, Name: /s/ Steven Boyd, Title: Managing Member
Issuer symbol
AVTX
Transactions as of
10 Mar 2022
Net transactions value
+$151,946
Form type
4
Filing time
14 Mar 2022, 17:38:41 UTC
Previous filing
07 Mar 2022
Next filing
19 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $18,226 +26,000 +0.05% $0.7010 47,376,000 10 Mar 2022 See Footnote F1
transaction AVTX Common Stock Purchase $68,780 +100,000 +0.21% $0.6878 47,476,000 11 Mar 2022 See Footnote F1
transaction AVTX Common Stock Purchase $64,940 +100,000 +0.21% $0.6494 47,576,000 14 Mar 2022 See Footnote F1
holding AVTX Common Stock 412,442 10 Mar 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities of Avalo Therapeutics, Inc. (the "Issuer") are directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the "Master Fund"), and may be deemed to be indirectly beneficially owned by: (i) Armistice Capital, LLC ("Armistice Capital"), as the investment manager of the Master Fund; and (ii) Steven Boyd, as the Managing Member of Armistice Capital ("Mr. Boyd", and collectively with the Master Fund and Armistice Capital, the "Reporting Persons"). Each of Armistice Capital and Mr. Boyd disclaim beneficial ownership of the reported securities except to the extent of their respective pecuniary interests therein, and this report shall not be deemed an admission that either of them are the beneficial owners of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
F2 These shares are directly owned by Mr. Boyd in his personal capacity.

Remarks:

Each of the Master Fund and Armistice Capital may be deemed a director by deputization of the Issuer by virtue of the fact that Steven Boyd, a representative of the Master Fund and Armistice Capital, currently serves on the Issuer's board of directors.